Literature DB >> 13332573

The excretory products of N-methyl-C14-erythromycin in rats.

C C LEE, R C ANDERSON, K K CHEN.   

Abstract

Entities:  

Keywords:  ERYTHROMYCIN/metabolism

Mesh：

Substances：

Year:  1956        PMID： 13332573

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN： 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  6 in total

Review 1.  Clinical pharmacokinetic properties of the macrolide antibiotics. Effects of age and various pathophysiological states (Part II).

Authors:  P Periti; T Mazzei; E Mini; A Novelli
Journal:  Clin Pharmacokinet       Date:  1989-05       Impact factor: 6.447

2.  Erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes P-450. Studies in rats and patients.

Authors:  P B Watkins; S A Murray; L G Winkelman; D M Heuman; S A Wrighton; P S Guzelian
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

3.  Pharmacokinetics and metabolism of rosaramicin in humans.

Authors:  C C Lin; M Chung; R Gural; D Schuessler; H K Kim; E Radwanski; A Marco; C DiGiore; S Symchowicz
Journal:  Antimicrob Agents Chemother       Date:  1984-10       Impact factor: 5.191

4.  Identification of glucocorticoid-inducible cytochromes P-450 in the intestinal mucosa of rats and man.

Authors:  P B Watkins; S A Wrighton; E G Schuetz; D T Molowa; P S Guzelian
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

5.  Tissue distribution and excretion of radioactively labelled compounds in the Wistar rat after administration of [N-methyl-14C]-erythromycin A.

Authors:  I O Kibwage; M Michiels; R Hendriks; T Cachet; A Verbruggen; J Hoogmartens; H Vanderhaeghe
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1989 Jan-Mar       Impact factor: 2.441

Review 6.  Late-Stage Carbon-14 Labeling and Isotope Exchange: Emerging Opportunities and Future Challenges.

Authors:  Victor Babin; Frédéric Taran; Davide Audisio
Journal:  JACS Au       Date:  2022-06-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.